These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

940 related articles for article (PubMed ID: 34238294)

  • 1. Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents.
    Zhu Y; Liu K; Chen M; Liu Y; Gao A; Hu C; Li H; Zhu H; Han H; Zhang J; Zhao Y
    Cardiovasc Diabetol; 2021 Jul; 20(1):137. PubMed ID: 34238294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The association between the triglyceride-glucose index and in-stent restenosis in patients undergoing percutaneous coronary intervention: a systematic review and meta-analysis.
    Jiang H; Liu Y; Guo H; Liu Z; Li Z
    BMC Cardiovasc Disord; 2024 May; 24(1):234. PubMed ID: 38702615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discordance between the triglyceride glucose index and fasting plasma glucose or HbA1C in patients with acute coronary syndrome undergoing percutaneous coronary intervention predicts cardiovascular events: a cohort study from China.
    Hu C; Zhang J; Liu J; Liu Y; Gao A; Zhu Y; Zhao Y
    Cardiovasc Diabetol; 2020 Jul; 19(1):116. PubMed ID: 32703284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Triglyceride-glucose index predicts adverse cardiovascular events in patients with diabetes and acute coronary syndrome.
    Wang L; Cong HL; Zhang JX; Hu YC; Wei A; Zhang YY; Yang H; Ren LB; Qi W; Li WY; Zhang R; Xu JH
    Cardiovasc Diabetol; 2020 Jun; 19(1):80. PubMed ID: 32534586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Triglyceride glucose index for predicting cardiovascular outcomes after percutaneous coronary intervention in patients with type 2 diabetes mellitus and acute coronary syndrome.
    Ma X; Dong L; Shao Q; Cheng Y; Lv S; Sun Y; Shen H; Wang Z; Zhou Y; Liu X
    Cardiovasc Diabetol; 2020 Mar; 19(1):31. PubMed ID: 32156279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impacts of triglyceride-glucose index on prognosis of patients with type 2 diabetes mellitus and non-ST-segment elevation acute coronary syndrome: results from an observational cohort study in China.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    Cardiovasc Diabetol; 2020 Jul; 19(1):108. PubMed ID: 32641127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic immune-inflammation index and in-stent restenosis in patients with acute coronary syndrome: a single-center retrospective study.
    Xie F; Yu Z; Xiong Y; Wu Z; Wu Y
    Eur J Med Res; 2024 Feb; 29(1):145. PubMed ID: 38409069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of the triglyceride glucose index combined with cystatin C for the prognosis of patients with acute coronary syndrome.
    Wang C; Liao P; Tang C; Chen C; Zhang X
    Front Endocrinol (Lausanne); 2024; 15():1423227. PubMed ID: 39257901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin resistance, coronary artery lesion complexity and adverse cardiovascular outcomes in patients with acute coronary syndrome.
    Chen Q; Xiong S; Ye T; Gao Y; Wang J; Li X; Li Y; Cui C; Liu H; Zhang Z; Cai L; Zheng J
    Cardiovasc Diabetol; 2024 May; 23(1):172. PubMed ID: 38755609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of insulin resistance on in-stent restenosis in patients undergoing coronary drug-eluting stent implantation after long-term angiographic follow-up.
    Zhao LP; Xu WT; Wang L; Li H; Shao CL; Gu HB; Chan SP; Xu HF; Yang XJ
    Coron Artery Dis; 2015 Jan; 26(1):5-10. PubMed ID: 25211654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triglyceride glucose index combined with plaque characteristics as a novel biomarker for cardiovascular outcomes after percutaneous coronary intervention in ST-elevated myocardial infarction patients: an intravascular optical coherence tomography study.
    Zhao X; Wang Y; Chen R; Li J; Zhou J; Liu C; Zhou P; Sheng Z; Chen Y; Song L; Zhao H; Yan H
    Cardiovasc Diabetol; 2021 Jun; 20(1):131. PubMed ID: 34183007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High triglyceride-glucose index is associated with poor cardiovascular outcomes in Chinese acute coronary syndrome patients without diabetes mellitus who underwent emergency percutaneous coronary intervention with drug-eluting stents.
    Zhang Y; Chu C; Zhong Z; Luo YB; Ning FF; Guo N
    Front Endocrinol (Lausanne); 2023; 14():1101952. PubMed ID: 36875470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-coated balloon angioplasty versus drug-eluting stent implantation in ACS patients with different angiographic patterns of in-stent restenosis.
    Xie H; Qiu M; Li X; Xiao Y; Mu Y; Wang G; Han Y
    Int J Cardiol; 2024 Nov; 415():132450. PubMed ID: 39147282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the long-term prognostic ability of triglyceride-glucose index for elderly acute coronary syndrome patients: a cohort study.
    Jiao Y; Su Y; Shen J; Hou X; Li Y; Wang J; Liu B; Qiu D; Sun Z; Chen Y; Xi Q; Shen M; Fu Z
    Cardiovasc Diabetol; 2022 Jan; 21(1):3. PubMed ID: 34991602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triglyceride-glucose index is associated with recurrent revascularization in patients with type 2 diabetes mellitus after percutaneous coronary intervention.
    Chen Q; Xiong S; Zhang Z; Yu X; Chen Y; Ye T; Yang S; Qi L; Chen X; Liu H; Zheng J; Cai L
    Cardiovasc Diabetol; 2023 Oct; 22(1):284. PubMed ID: 37865753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triglyceride-Glucose Index as a Surrogate Marker of Insulin Resistance for Predicting Cardiovascular Outcomes in Nondiabetic Patients with Non-ST-Segment Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.
    Zhao Q; Zhang TY; Cheng YJ; Ma Y; Xu YK; Yang JQ; Zhou YJ
    J Atheroscler Thromb; 2021 Nov; 28(11):1175-1194. PubMed ID: 33191314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors.
    Zhu Y; Chen M; Liu K; Gao A; Kong X; Liu Y; Han H; Li H; Zhu H; Zhang J; Zhao Y
    J Atheroscler Thromb; 2022 Aug; 29(8):1226-1235. PubMed ID: 34497172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triglyceride-glucose index as a predictor of cardiac adverse events in acute coronary syndrome patients undergoing percutaneous coronary intervention: role of diabetes.
    Khalaji A; Behnoush AH; Pasebani Y; Rafati A; Mahmoodi T; Arzhangzadeh A; Shamshiri Khamene S; MohammadKhawajah I; Mehrani M; Vasheghani-Farahani A; Masoudkabir F; Najafi K; Askari MK; Harrison A; Nelson JR; Hosseini K; Hernandez AV
    BMC Cardiovasc Disord; 2024 Sep; 24(1):514. PubMed ID: 39333881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride-glucose index for predicting repeat revascularization and in-stent restenosis in patients with chronic coronary syndrome undergoing percutaneous coronary intervention.
    Guo X; Shen R; Yan S; Su Y; Ma L
    Cardiovasc Diabetol; 2023 Mar; 22(1):43. PubMed ID: 36864455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGF-23 correlates with endocrine and metabolism dysregulation, worse cardiac and renal function, inflammation level, stenosis degree, and independently predicts in-stent restenosis risk in coronary heart disease patients underwent drug-eluting-stent PCI.
    Song T; Fu Y; Wang Y; Li W; Zhao J; Wang X; Wang H; Zhao Y; Fu X
    BMC Cardiovasc Disord; 2021 Jan; 21(1):24. PubMed ID: 33413149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.